New technology is allowing teams to analyze data at faster rates and make decisions much sooner than they previously could.
Ken McLaren
Advertisement
Articles by Ken McLaren
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
BioMarin Reaches $4.8 Billion Definitive Agreement to Acquire Amicus Therapeutics
2
Senate Passes Biosecure Act
3
President Trump Announces Nine More TrumpRx Participants
4
Eli Lilly Announces Topline Results From Phase III Trial Studying Oral GLP-1 Therapy Orforglipron
5